Skip to main content
logo
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
10.09
+0.01 (0.10%)
At close: Aug 14, 2026, 4:00 PM EDT
10.29
+0.20 (1.98%)
After-hours: Aug 14, 2026, 7:59 PM EDT

CRBP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
195151144271477
Market Cap Growth
66.09%4.94%437.89%93.01%-82.05%-26.60%
Enterprise Value
8149-1221-27-4
Last Close Price
10.098.1411.806.043.3218.47

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----87.45
PB Ratio
1.841.021.01-3.870.421.12
P/TBV Ratio
1.911.021.01-0.421.12

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.010.02-3.020.760.39
Net Debt / Equity Ratio
-1.11-1.10-1.020.00-1.03-1.03
Net Debt / EBITDA Ratio
1.071.903.0301.001.29
Net Debt / FCF Ratio
1.312.513.490.000.911.47
Asset Turnover
-----0.01
Quick Ratio
5.567.9612.610.664.685.74
Current Ratio
5.718.0712.940.744.765.89
Return on Equity (ROE)
-95.58%-54.18%-59.34%-341.99%-82.95%-79.80%
Return on Assets (ROA)
-53.00%-32.91%-33.07%-59.57%-25.02%-33.32%
Return on Capital Employed (ROCE)
-101.30%-57.80%-33.80%1244.60%-64.90%-61.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-52.22%-52.07%-27.98%-166.94%-305.90%-59.19%
FCF Yield
-44.42%-42.76%-29.08%-135.11%-271.30%-62.56%
Buyback Yield / Dilution
-37.35%-22.00%-152.23%-3.76%-1.85%-57.23%
SEC Filings: 10-K · 10-Q